MESNA (sodium 2-mercaptoethanesulfonate) for prevention of contrast medium-induced nephrotoxicity - controlled trial.

Ludwig, U; Riedel, M K; Backes, M; Imhof, A; Muche, R; Keller, F

Ludwig, U; Riedel, M K; Backes, M; Imhof, A; Muche, R; Keller, F.

Affiliation

Ludwig U; Nephrology Division, Clinic for Internal Medicine I, Center of Internal Medicine, University Hospital Ulm, Ulm, Germany. ulla.ludwig@uniklinik-ulm.de

Clin Nephrol ; 75(4): 302-8, 2011 Apr.

Article in En | MEDLINE | ID: mdl-21426884

Subject(s)

Contrast Media/adverse effects; Kidney Diseases/chemically induced; Kidney Diseases/prevention & control; Mesna/therapeutic use; Protective Agents/therapeutic use; Aged; Double-Blind Method; Female; Humans; Kidney Function Tests; Male; Middle Aged; Placebos; Statistics, Nonparametric; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Mesna / Contrast Media / Protective Agents / Kidney Diseases Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Nephrol Year: 2011 Document type: Article Affiliation country: Germany Country of publication: Germany

Search on Google

Add to My VHL

XML

PubMed Links